Summary

Market Overview

According to DIResearch＇s in-depth investigation and research, the global Onychomycosis (Tinea Unguium) Drug market size will reach 1,743.02 Million USD in 2026 and is projected to reach 2,167.11 Million USD by 2033, with a CAGR of 3.16% (2026-2033). Notably, the China Onychomycosis (Tinea Unguium) Drug market has changed rapidly in the past few years. By 2026, China＇s market size is expected to be Million USD, representing approximately % of the global market share.

Research Summary

Onychomycosis, also known as tinea unguium, refers to a fungal infection of the nails, most commonly affecting the toenails but can also affect the fingernails. Onychomycosis drugs, or antifungal medications, are used to treat and manage this condition. These drugs can be administered orally, topically, or through a combination of both, depending on the severity of the infection. They work by inhibiting the growth of the fungi responsible for the nail infection, ultimately leading to the elimination of the fungal presence and the restoration of healthy nail growth. Onychomycosis drugs play a crucial role in addressing a common and often persistent condition that can impact the appearance and health of the nails, and they are typically prescribed and monitored by healthcare professionals.

The major global suppliers of Onychomycosis (Tinea Unguium) Drug include Bausch Health, Kaken Pharmaceutical, Galderma, Johnson & Johnson, Sato Pharmaceutical , Karo Healthcare, Pfizer, Qilu Pharmaceutical, Jiangsu Fubang Pharmaceutical, Chengdu Brilliant Pharmaceutical, Harbin Medisan Pharmaceutical, Letai Pharmaceutical, Shandong Buchang Pharmaceuticals, Hubei Heng＇an Fulin Pharmaceutical, Honz Pharmaceutical, Tianjin Lisheng Pharmaceutical, Nanjing Cuccess Pharmaceutical, Shanghai Huanhua Pharmaceutical, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Onychomycosis (Tinea Unguium) Drug. Focus on analysing the market share, product portfolio, prices, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Onychomycosis (Tinea Unguium) Drug market. The report data covers historical data from 2021 to 2025, based year in 2026 and forecast data from 2027 to 2033.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Onychomycosis (Tinea Unguium) Drug market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Onychomycosis (Tinea Unguium) Drug industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.  

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Suppliers of Onychomycosis (Tinea Unguium) Drug Include:

Bausch Health

Kaken Pharmaceutical

Galderma

Johnson & Johnson

Sato Pharmaceutical 

Karo Healthcare

Pfizer

Qilu Pharmaceutical

Jiangsu Fubang Pharmaceutical

Chengdu Brilliant Pharmaceutical

Harbin Medisan Pharmaceutical

Letai Pharmaceutical

Shandong Buchang Pharmaceuticals

Hubei Heng＇an Fulin Pharmaceutical

Honz Pharmaceutical

Tianjin Lisheng Pharmaceutical

Nanjing Cuccess Pharmaceutical

Shanghai Huanhua Pharmaceutical

Onychomycosis (Tinea Unguium) Drug Product Segment Include:

Oral Drug

Topical Drug

Onychomycosis (Tinea Unguium) Drug Product Application Include:

Age under 18

Age 18-50

Age above 50




Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Onychomycosis (Tinea Unguium) Drug Industry PESTEL Analysis

Chapter 3: Global Onychomycosis (Tinea Unguium) Drug Industry Porter’s Five Forces Analysis

Chapter 4: Global Onychomycosis (Tinea Unguium) Drug Major Regional Market Size and Forecast Analysis

Chapter 5: Global Onychomycosis (Tinea Unguium) Drug Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Passenger Onychomycosis (Tinea Unguium) Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Onychomycosis (Tinea Unguium) Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Onychomycosis (Tinea Unguium) Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Onychomycosis (Tinea Unguium) Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Onychomycosis (Tinea Unguium) Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Onychomycosis (Tinea Unguium) Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Onychomycosis (Tinea Unguium) Drug Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

ページTOPに戻る

Table of Contents

Table of Contents

1 Onychomycosis (Tinea Unguium) Drug Market Overview

  1.1 Product Definition and Statistical Scope

   1.2 Onychomycosis (Tinea Unguium) Drug Product by Type

       1.2.1 Oral Drug

       1.2.2 Topical Drug

   1.3 Onychomycosis (Tinea Unguium) Drug Product by Application

       1.3.1 Age under 18

       1.3.2 Age 18-50

       1.3.3 Age above 50

   1.4 Global Onychomycosis (Tinea Unguium) Drug Market Size Analysis (2021-2033)

   1.5 Onychomycosis (Tinea Unguium) Drug Market Development Status and Trends

       1.5.1 Onychomycosis (Tinea Unguium) Drug Industry Development Status Analysis

       1.5.2 Onychomycosis (Tinea Unguium) Drug Industry Development Trends Analysis

2 Onychomycosis (Tinea Unguium) Drug Market PESTEL Analysis

   2.1 Political Factors Analysis

   2.2 Economic Factors Analysis

   2.3 Social Factors Analysis

   2.4 Technological Factors Analysis

   2.5 Environmental Factors Analysis

   2.6 Legal Factors Analysis

3 Onychomycosis (Tinea Unguium) Drug Market Porter's Five Forces Analysis

   3.1 Competitive Rivalry

   3.2 Threat of New Entrants

   3.3 Bargaining Power of Suppliers

   3.4 Bargaining Power of Buyers

   3.5 Threat of Substitutes

4 Global Onychomycosis (Tinea Unguium) Drug Market Analysis by Regions

   4.1 Onychomycosis (Tinea Unguium) Drug Overall Market: 2025 VS 2026 VS 2033

   4.2 Global Onychomycosis (Tinea Unguium) Drug Revenue and Forecast Analysis (2021-2033)

       4.2.1 Global Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Region (2021-2026)

       4.2.2 Global Onychomycosis (Tinea Unguium) Drug Revenue and Market Share Forecast by Region (2027-2033)

5 Global Onychomycosis (Tinea Unguium) Drug Market Size by Type and Application

   5.1 Global Onychomycosis (Tinea Unguium) Drug Market Size by Type (2021-2033)

   5.2 Global Onychomycosis (Tinea Unguium) Drug Market Size by Application (2021-2033)

6 North America

   6.1 North America Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate Analysis (2021-2033)

   6.2 North America Key Suppliers Analysis

   6.3 North America Onychomycosis (Tinea Unguium) Drug Market Size by Type

   6.4 North America Onychomycosis (Tinea Unguium) Drug Market Size by Application

   6.5 North America Onychomycosis (Tinea Unguium) Drug Market Size by Country

       6.5.1 US

       6.5.2 Canada

7 Europe

   7.1 Europe Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate Analysis (2021-2033)

   7.2 Europe Key Suppliers Analysis

   7.3 Europe Onychomycosis (Tinea Unguium) Drug Market Size by Type

   7.4 Europe Onychomycosis (Tinea Unguium) Drug Market Size by Application

   7.5 Europe Onychomycosis (Tinea Unguium) Drug Market Size by Country

       7.5.1 Germany

       7.5.2 France

       7.5.3 United Kingdom

       7.5.4 Italy

       7.5.5 Spain

       7.5.6 Benelux

8 China

   8.1 China Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate Analysis (2021-2033)

   8.2 China Key Suppliers Analysis

   8.3 China Onychomycosis (Tinea Unguium) Drug Market Size by Type

   8.4 China Onychomycosis (Tinea Unguium) Drug Market Size by Application

9 APAC (excl. China)

   9.1 APAC (excl. China) Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate Analysis (2021-2033)

   9.2 APAC (excl. China) Key Suppliers Analysis

   9.3 APAC (excl. China) Onychomycosis (Tinea Unguium) Drug Market Size by Type

   9.4 APAC (excl. China) Onychomycosis (Tinea Unguium) Drug Market Size by Application

   9.5 APAC (excl. China) Onychomycosis (Tinea Unguium) Drug Market Size by Country

       9.5.1 Japan

       9.5.2 South Korea

       9.5.3 India

       9.5.4 Australia

       9.5.5 Southeast Asia

10 Latin America

   10.1 Latin America Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate Analysis (2021-2033)

   10.2 Latin America Key Suppliers Analysis

   10.3 Latin America Onychomycosis (Tinea Unguium) Drug Market Size by Type

   10.4 Latin America Onychomycosis (Tinea Unguium) Drug Market Size by Application

   10.5 Latin America Onychomycosis (Tinea Unguium) Drug Market Size by Country

       10.5.1 Mexico

       10.5.2 Brazil

11 Middle East & Africa

   11.1 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate Analysis (2021-2033)

   11.2 Middle East & Africa Key Suppliers Analysis

   11.3 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size by Type

   11.4 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size by Application

   11.5 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size by Country

       11.5.1 Saudi Arabia

       11.5.2 South Africa

12 Competition by Suppliers

   12.1 Global Onychomycosis (Tinea Unguium) Drug Market Revenue by Key Suppliers (2021-2033)

   12.2 Onychomycosis (Tinea Unguium) Drug Competitive Landscape Analysis and Market Dynamic

       12.2.1 Onychomycosis (Tinea Unguium) Drug Competitive Landscape Analysis

       12.2.2 Global Key Suppliers Headquarter Location and Key Area Sales

       12.2.3 Market Dynamic

13 Key Companies Analysis

   13.1 Bausch Health

       13.1.1 Bausch Health Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.1.2 Bausch Health Onychomycosis (Tinea Unguium) Drug Product Portfolio

       13.1.3 Bausch Health Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.2 Kaken Pharmaceutical

       13.2.1 Kaken Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.2.2 Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Portfolio

       13.2.3 Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.3 Galderma

       13.3.1 Galderma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.3.2 Galderma Onychomycosis (Tinea Unguium) Drug Product Portfolio

       13.3.3 Galderma Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.4 Johnson & Johnson

       13.4.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.4.2 Johnson & Johnson Onychomycosis (Tinea Unguium) Drug Product Portfolio

       13.4.3 Johnson & Johnson Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.5 Sato Pharmaceutical 

       13.5.1 Sato Pharmaceutical  Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.5.2 Sato Pharmaceutical  Onychomycosis (Tinea Unguium) Drug Product Portfolio

       13.5.3 Sato Pharmaceutical  Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.6 Karo Healthcare

       13.6.1 Karo Healthcare Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.6.2 Karo Healthcare Onychomycosis (Tinea Unguium) Drug Product Portfolio

       13.6.3 Karo Healthcare Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.7 Pfizer

       13.7.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.7.2 Pfizer Onychomycosis (Tinea Unguium) Drug Product Portfolio

       13.7.3 Pfizer Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.8 Qilu Pharmaceutical

       13.8.1 Qilu Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.8.2 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Portfolio

       13.8.3 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.9 Jiangsu Fubang Pharmaceutical

       13.9.1 Jiangsu Fubang Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.9.2 Jiangsu Fubang Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Portfolio

       13.9.3 Jiangsu Fubang Pharmaceutical Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.10 Chengdu Brilliant Pharmaceutical

       13.10.1 Chengdu Brilliant Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.10.2 Chengdu Brilliant Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Portfolio

       13.10.3 Chengdu Brilliant Pharmaceutical Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.11 Harbin Medisan Pharmaceutical

       13.11.1 Harbin Medisan Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.11.2 Harbin Medisan Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Portfolio

       13.11.3 Harbin Medisan Pharmaceutical Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.12 Letai Pharmaceutical

       13.12.1 Letai Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.12.2 Letai Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Portfolio

       13.12.3 Letai Pharmaceutical Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.13 Shandong Buchang Pharmaceuticals

       13.13.1 Shandong Buchang Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.13.2 Shandong Buchang Pharmaceuticals Onychomycosis (Tinea Unguium) Drug Product Portfolio

       13.13.3 Shandong Buchang Pharmaceuticals Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.14 Hubei Heng＇an Fulin Pharmaceutical

       13.14.1 Hubei Heng＇an Fulin Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.14.2 Hubei Heng＇an Fulin Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Portfolio

       13.14.3 Hubei Heng＇an Fulin Pharmaceutical Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.15 Honz Pharmaceutical

       13.15.1 Honz Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.15.2 Honz Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Portfolio

       13.15.3 Honz Pharmaceutical Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.16 Tianjin Lisheng Pharmaceutical

       13.16.1 Tianjin Lisheng Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.16.2 Tianjin Lisheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Portfolio

       13.16.3 Tianjin Lisheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.17 Nanjing Cuccess Pharmaceutical

       13.17.1 Nanjing Cuccess Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.17.2 Nanjing Cuccess Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Portfolio

       13.17.3 Nanjing Cuccess Pharmaceutical Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.18 Shanghai Huanhua Pharmaceutical

       13.18.1 Shanghai Huanhua Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.18.2 Shanghai Huanhua Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Portfolio

       13.18.3 Shanghai Huanhua Pharmaceutical Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

14 Industry Chain Analysis

   14.1 Onychomycosis (Tinea Unguium) Drug Industry Chain Analysis

   14.2 Onychomycosis (Tinea Unguium) Drug Typical Downstream Customers

   14.3 Onychomycosis (Tinea Unguium) Drug Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

   16.1 Methodology/Research Approach

   16.2 Research Scope

   16.3 Benchmarks and Assumptions

   16.4 Date Source

       16.4.1 Primary Sources

       16.4.2 Secondary Sources

   16.5 Data Cross Validation

   16.6 Disclaimer